Neonatal lymphangioma: Experience in a single institution
Journal
Clinical Neonatology
Journal Volume
11
Journal Issue
1
Pages
5-8
Date Issued
2004
Abstract
Lymphangioma is a rare congenital malformation composed of cystically dilated lymphatics. The purpose of this study was to outline the natural course of neonatal lymphangioma and the results of surgical excision and other treatment options. In a retrospective study, 29 neonates diagnosed within one month of age with lymphangioma from 1990 to 2001 in one institution were reviewed. The most common presentation was a noticeable mass which occurred in all patients. The most common location was the cervical region (62%). Surgical excision was performed in 25 patients, with a residual or recurrence rate of 40%. Complications included peripheral facial nerve palsy in four patients, wound infection in three, and partial wound necrosis in one. Intralesion injection of sclerosing agent (OK-432) was administered to three patients and the mass was resolved in one of them. The lymphangioma of one patient spontaneously regressed without treatment. In conclusion, neonatal lymphangioma is a rare disease with a low mortality rate. Surgery is effective treatment if the mass is resectable. Intralesion injection of OK-432 may be considered as an alternative therapy if surgery is not passible.
SDGs
Other Subjects
betamethasone; picibanil; cervical lymph node; clinical article; clinical feature; cystic lymphangioma; facial nerve paralysis; female; histopathology; human; human tissue; lymphadenectomy; male; newborn; newborn disease; newborn mortality; recurrence risk; retrospective study; review; tissue necrosis; treatment indication; tumor localization; tumor recurrence; wound infection
Type
review